Quick Answer
Zhengye Biotechnology Holding Ltd reported R&D Expense of $1.75 million for fiscal year 2024.
Zhengye Biotechnology Holding Ltd R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $1.75M | -85.3% |
| 2023 | $11.90M | -11.3% |
| 2022 | $13.42M | — |
- Zhengye Biotechnology Holding Ltd showed a decrease of -85.3% in R&D Expense compared to the prior fiscal year.
- Over the 2022–2024 period, Zhengye Biotechnology Holding Ltd’s r&d expense has declined by 86.9% (from $13.42 million to $1.75 million).
- The most recent figure is from Zhengye Biotechnology Holding Ltd’s fiscal year 2024 report (Form 20-F), filed with the SEC on July 3, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: